Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics, 2008.
CA Cancer J Clin 2008,58(2):71–96.
Article
PubMed
Google Scholar
Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K: Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition).
Chest 2007,132(3 Suppl):234S-242S.
Article
PubMed
Google Scholar
Ries L, Eisner M, Kosary C, Hankey B, Miller B, Clegg L, Mariotto A, Feuer E, Edwards B: SEER Cancer Statistics Review, 1975–2002. National Cancer Institute. Bethesda, MD; 2002.
Google Scholar
Henschke CI, Yankelevitz DF: CT screening for lung cancer: update 2007.
Oncologist 2008,13(1):65–78.
Article
PubMed
Google Scholar
Sone S, Li F, Yang ZG, Honda T, Maruyama Y, Takashima S, Hasegawa M, Kawakami S, Kubo K, Haniuda M, et al.: Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner.
Br J Cancer 2001,84(1):25–32.
Article
CAS
PubMed
PubMed Central
Google Scholar
Artinian V, Kvale PA: Update in screening of lung cancer.
Respirology 2005,10(5):558–566.
Article
PubMed
Google Scholar
Marshall E: Medicine. A bruising battle over lung scans.
Science 2008,320(5876):600–603.
Article
CAS
PubMed
Google Scholar
Reich JM: A critical appraisal of overdiagnosis: estimates of its magnitude and implications for lung cancer screening.
Thorax 2008,63(4):377–383.
Article
CAS
PubMed
Google Scholar
Comtesse N, Zippel A, Walle S, Monz D, Backes C, Fischer U, Mayer J, Ludwig N, Hildebrandt A, Keller A, et al.: Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets.
Proc Natl Acad Sci USA 2005,102(27):9601–9606.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brichory F, Beer D, Le Naour F, Giordano T, Hanash S: Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer.
Cancer Res 2001,61(21):7908–7912.
CAS
PubMed
Google Scholar
Brichory FM, Misek DE, Yim AM, Krause MC, Giordano TJ, Beer DG, Hanash SM: An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer.
Proc Natl Acad Sci USA 2001,98(17):9824–9829.
Article
CAS
PubMed
PubMed Central
Google Scholar
He P, Naka T, Serada S, Fujimoto M, Tanaka T, Hashimoto S, Shima Y, Yamadori T, Suzuki H, Hirashima T, et al.: Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer.
Cancer Sci 2007,98(8):1234–1240.
Article
CAS
PubMed
Google Scholar
Tureci O, Mack U, Luxemburger U, Heinen H, Krummenauer F, Sester M, Sester U, Sybrecht GW, Sahin U: Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1.
Cancer Lett 2006,236(1):64–71.
Article
PubMed
Google Scholar
Yamaguchi K, Patturajan M, Trink B, Usadel H, Koch W, Jen J, Sidransky D: Circulating antibodies to p40(AIS) in the sera of respiratory tract cancer patients.
Int J Cancer 2000,89(6):524–528.
Article
CAS
PubMed
Google Scholar
Yamamoto A, Shimizu E, Ogura T, Sone S: Detection of auto-antibodies against L-myc oncogene products in sera from lung cancer patients.
Int J Cancer 1996,69(4):283–289.
Article
CAS
PubMed
Google Scholar
Chapman CJ, Murray A, McElveen JE, Sahin U, Luxemburger U, Tureci O, Wiewrodt R, Barnes AC, Robertson JF: Autoantibodies in lung cancer: possibilities for early detection and subsequent cure.
Thorax 2008,63(3):228–233.
Article
CAS
PubMed
Google Scholar
Patz EF Jr, Campa MJ, Gottlin EB, Kusmartseva I, Guan XR, Herndon JE: Panel of serum biomarkers for the diagnosis of lung cancer.
J Clin Oncol 2007,25(35):5578–5583.
Article
PubMed
Google Scholar
Zhong L, Coe SP, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA: Profiling tumor-associated antibodies for early detection of non-small cell lung cancer.
J Thorac Oncol 2006,1(6):513–519.
Article
PubMed
Google Scholar
Zhong L, Hidalgo GE, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA: Using protein microarray as a diagnostic assay for non-small cell lung cancer.
Am J Respir Crit Care Med 2005,172(10):1308–1314.
Article
PubMed
PubMed Central
Google Scholar
Leidinger P, Keller A, Ludwig N, Rheinheimer S, Hamacher J, Huwer H, Stehle I, Lenhof HP, Meese E: Toward an early diagnosis of lung cancer: an autoantibody signature for squamous cell lung carcinoma.
Int J Cancer 2008,123(7):1631–1636.
Article
CAS
PubMed
Google Scholar
Bussow K, Cahill D, Nietfeld W, Bancroft D, Scherzinger E, Lehrach H, Walter G: A method for global protein expression and antibody screening on high-density filters of an arrayed cDNA library.
Nucleic Acids Res 1998,26(21):5007–5008.
Article
CAS
PubMed
PubMed Central
Google Scholar
Leidinger P, Keller A, Heisel S, Ludwig N, Rheinheimer S, Klein V, Andres C, Hamacher J, Huwer H, Stephan B, et al.: Novel autoantigens immunogenic in COPD patients.
Respir Res 2009, 10:20.
Article
PubMed
PubMed Central
Google Scholar
Soille P: Morphological Image Analysis. Second edition. Springer, Berlin; 2003.
Google Scholar
Vapnik V: The Nature of Statistical Learning Theory. Springer; 2000.
Hirsch FR, Franklin WA, Gazdar AF, Bunn PA Jr: Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology.
Clin Cancer Res 2001,7(1):5–22.
CAS
PubMed
Google Scholar
Cassidy A, Duffy SW, Myles JP, Liloglou T, Field JK: Lung cancer risk prediction: a tool for early detection.
Int J Cancer 2007,120(1):1–6.
Article
CAS
PubMed
Google Scholar
Humphrey LL, Teutsch S, Johnson M: Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force.
Ann Intern Med 2004,140(9):740–753.
Article
PubMed
Google Scholar
Lobo ED, Hansen RJ, Balthasar JP: Antibody pharmacokinetics and pharmacodynamics.
J Pharm Sci 2004,93(11):2645–2668.
Article
CAS
PubMed
Google Scholar
Rauch TA, Zhong X, Wu X, Wang M, Kernstine KH, Wang Z, Riggs AD, Pfeifer GP: High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer.
Proc Natl Acad Sci USA 2008,105(1):252–257.
Article
CAS
PubMed
Google Scholar
Weir BA, Woo MS, Getz G, Perner S, Ding L, Beroukhim R, Lin WM, Province MA, Kraja A, Johnson LA, et al.: Characterizing the cancer genome in lung adenocarcinoma.
Nature 2007,450(7171):893–898.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ogiwara H, Kohno T, Nakanishi H, Nagayama K, Sato M, Yokota J: Unbalanced translocation, a major chromosome alteration causing loss of heterozygosity in human lung cancer.
Oncogene 2008,27(35):4788–4797.
Article
CAS
PubMed
Google Scholar
Tan D, Deeb G, Wang J, Slocum HK, Winston J, Wiseman S, Beck A, Sait S, Anderson T, Nwogu C, et al.: HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization.
Diagn Mol Pathol 2003,12(4):201–211.
Article
CAS
PubMed
Google Scholar